Evidence map›Paper›PMID 42601600›Full record

ArticleBMC infectious diseases2026

Epidemiological characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China, 2010-2024: a fifteen-year national surveillance analysis.

Qian Ren, Hui-Jie Qin, Si-Han Li, Shi-Jian Zhou, Jun-Yuan Chen, Di Mu, Yu Li, Qiu-Lan Chen, Yan-Ping Zhang

Abstract read
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qian Ren *National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Division of Infectious Disease, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Changbai Road, Changping District, Beijing, 102206, China.
Hui-Jie Qin *School of Public Health, Guangxi Medical University, Nanning, China.
Si-Han LiNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Division of Infectious Disease, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Changbai Road, Changping District, Beijing, 102206, China.
Shi-Jian ZhouNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Division of Infectious Disease, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Changbai Road, Changping District, Beijing, 102206, China.
Jun-Yuan ChenSchool of Public Health, Guangxi Medical University, Nanning, China.
Di MuNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Division of Infectious Disease, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Changbai Road, Changping District, Beijing, 102206, China.
Yu LiNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Division of Infectious Disease, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Changbai Road, Changping District, Beijing, 102206, China.
Qiu-Lan ChenNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Division of Infectious Disease, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Changbai Road, Changping District, Beijing, 102206, China.
Yan-Ping ZhangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Division of Infectious Disease, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Changbai Road, Changping District, Beijing, 102206, China. zhangyp@chinacdc.cn.

Funding

Comprehensive Prevention and Control of Diseases program 1023932600200110000011Emergency Response Mechanism Operation Program 102393220020010000017Young Scholar Science Foundation of China CDC 2024A108
6 · The paper itself

Abstract

backgroundSevere fever with thrombocytopenia syndrome (SFTS) incidence has risen steadily in China since the disease was first identified in 2009, with both case numbers and the geographic scope of reporting expanding over time. This study analyzed national surveillance data from 2010 to 2024 to characterize the evolving epidemiological patterns of SFTS.

methodsThis retrospective descriptive study included clinically diagnosed and laboratory-confirmed SFTS cases from China Information System for Disease Control and Prevention (CISDCP) (2010-2024). Joinpoint regression was used to analyze incidence trends. Case fatality rate (CFR) differences were assessed by chi-squared or Fisher's exact tests, and the temporal trend was assessed by linear regression.

resultsDuring 2010-2024, a total of 30 provinces reported 34,055 cases. From 2010 to 2024, the incidence rate of SFTS in China showed a fluctuating upward trend, with an average annual percent change (AAPC) of 43.28% (95% confidence interval [CI]: 43.23%-43.33%;P < 0.01). Most cases were sporadic, with some regional clustering and rapid geographic expansion to previously unaffected areas. The number of reported cases in Anhui Province began to rise rapidly in 2022, making it the province with the highest number of reported cases in China in 2023 and 2024. The average CFR was 4.79%, and the CFR increased with age, reaching 9.15% among those aged 85 years and above.

conclusionsDuring the period from 2010 to 2024, SFTS in China exhibited a marked increase in reported incidence and considerable geographical expansion. The disease is no longer confined to traditional high-risk areas; the rapid rise in cases in province such as Anhui suggests a critical need to re-evaluate the ecological and social factors driving its transmission. Although the overall population CFR showed a declining trend, mortality risk among elderly subgroups still needs attention.

Indexed as

Severe Fever with Thrombocytopenia SyndromeAdolescentAgedAged, 80 and overChildChild, PreschoolChinaEpidemiological MonitoringFemaleHumansIncidenceMaleMiddle AgedPhlebovirusRetrospective StudiesYoung AdultCase fatality rateChinaGeographic expansionJoinpoint regressionSevere fever with thrombocytopenia syndromeSurveillanceTick-borne disease

Identifiers

PMID42601600
PMCPMC13474535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.